Cargando…
A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia
BACKGROUND: Cognitive impairment is among the core dimensions in schizophrenia and is a significant predictor of everyday functioning in people with schizophrenia. Given the enormous burden of schizophrenia, the search for its clinically relevant biomarkers is essential. Researchers have been trying...
Autores principales: | Chumakov, Egor, Dorofeikova, Mariia, Tsyrenova, Kristina, Petrova, Nataliia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298757/ https://www.ncbi.nlm.nih.gov/pubmed/35873262 http://dx.doi.org/10.3389/fpsyt.2022.943869 |
Ejemplares similares
-
A Phenomenal Depiction of Paranoid Schizophrenia With Auditory Hallucinations: A Case Report
por: Kakar, Gauri, et al.
Publicado: (2023) -
The Interaction of BDNF and NTRK2 Gene Increases the Susceptibility of Paranoid Schizophrenia
por: Lin, Zheng, et al.
Publicado: (2013) -
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
por: Nieto, Rodrigo R., et al.
Publicado: (2021) -
A Case Report of Leukocytosis During Modified Electroconvulsive Therapy of Paranoid Personality Disorder
por: Mu, Xingyu, et al.
Publicado: (2022) -
Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia
por: Huo, Lijuan, et al.
Publicado: (2021)